(Q42981508)

12 November 2017

title

Global burden of hepatitis C: considerations for healthcare providers in the United States (English)

1 reference

12 November 2017

main subject

United States of America

0 references

1 reference

Francisco M Averhoff

1

1 reference

12 November 2017

Nancy Glass

series ordinal

2

1 reference

12 November 2017

Deborah Holtzman

series ordinal

3

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 July 2012

1 reference

Clinical Infectious Diseases

12 November 2017

published in

1 reference

12 November 2017

volume

55 Suppl 1

1 reference

12 November 2017

page(s)

S10-5

1 reference

Global burden of disease (GBD) for hepatitis C.

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS361

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS361

Epidemiology of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS361

A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS361

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS361

Global epidemiology of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS361

Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS361

Trends and projections of hepatitis C virus epidemiology in Latin America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS361

Global estimates of prevalence of HCV infection among injecting drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS361

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS361

The global burden of disease attributable to contaminated injections given in health care settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS361

Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS361

The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS361

Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS361

Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS361

Community and personal risk factors for hepatitis C virus infection: a survey of 23,820 residents in Taiwan in 1991-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS361

Liver Disease in the HIV–Infected Individual

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS361

The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS361

Hepatitis C and HIV-1 coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS361

HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS361

Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS361

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS361

21 January 2018

Identifiers

DOI

10.1093/CID/CIS361

1 reference

12 November 2017

1 reference